ADMS
Adamas Pharmaceuticals
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
84 hedge funds and large institutions have $243M invested in Adamas Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 23 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 14
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $332K
Holders
84
Holding in Top 10
6
Calls
–
Puts
$332K
Top Buyers
| 1 | +$8.21M | |
| 2 | +$7.37M | |
| 3 | +$7.17M | |
| 4 |
BOS
Bingham Osborn & Scarborough
San Francisco,
California
|
+$3.1M |
| 5 |
JGC
J. Goldman & Co
New York
|
+$2.56M |
Top Sellers
| 1 | -$7.83M | |
| 2 | -$3.03M | |
| 3 | -$1.57M | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.55M |
| 5 |
IHM
Iguana Healthcare Management
New York
|
-$1.51M |